CNS-focused biopharma commercializing therapies and expanding into oncology
SK Life Science is the U.S. arm of SK Biopharmaceuticals, developing and commercializing CNS treatments with an oncology push. Its stack pairs pharma-specific tools (SAS, CDISC, NONMEM, Veeva PromoMats) with an unusually deep GenAI layer (LangChain, LangGraph, LlamaIndex, RAG, Hugging Face), signaling internal AI tooling ambitions. The stack and projects also point to an ERP overhaul, with an SAP PCE rollout and a newly sought Enterprise Applications Director.
Notable leadership hires: Enterprise Applications Director
SK Life Science, Inc. is a U.S. subsidiary of SK Biopharmaceuticals and part of SK Group, headquartered in Paramus, New Jersey. Founded in 2002, the privately held company employs 201–500 people. It focuses on treatments for central nervous system disorders and is extending its pipeline into oncology. Operations span clinical development, medical affairs, manufacturing science with contract manufacturers, and commercial sales of CNS products. Hiring activity covers the United States and Canada.
SK Life Science runs on Azure and AWS with Intune and Microsoft Sentinel, uses SAP, Coupa, Concur and Workato for enterprise ops, SAS, CDISC and NONMEM for clinical analytics, and LangChain, LlamaIndex and PyTorch for AI work.
Yes, hiring is accelerating, weighted toward engineering, operations and research roles at senior and director levels, including an Enterprise Applications Director, across the United States and Canada.
Current initiatives include an SAP PCE implementation, purchase order rollout, technology transfer to CMO sites for NDA submission, disaster recovery testing, and commercialization of its CNS products.
Other companies in the same industry, closest in size
SK Life Science, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.